Cargando…
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
RTK plays important roles in many cellular signaling processes involved in cancer growth and development. ALK, TRKA, TRKB, TRKC, and ROS1 are RTKs involved in several canonical pathways related to oncogenesis. These proteins can be genetically altered in malignancies, leading to receptor activation...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204873/ https://www.ncbi.nlm.nih.gov/pubmed/30425456 http://dx.doi.org/10.2147/DDDT.S147384 |